Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasion.
Prolo LM, Li A, Owen SF, Parker JJ, Foshay K, Nitta RT, Morgens DW, Bolin S, Wilson CM, Vega L JCM, Luo EJ, Nwagbo G, Waziri A, Li G, Reimer RJ, Bassik MC, Grant GA.
Prolo LM, et al. Among authors: parker jj.
Sci Rep. 2019 Sep 30;9(1):14020. doi: 10.1038/s41598-019-50160-w.
Sci Rep. 2019.
PMID: 31570734
Free PMC article.